Menu
GeneBe

rs35256489

Variant summary

Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM1PM2PP3_ModeratePP5_Very_Strong

The NM_000518.5(HBB):c.332T>C(p.Leu111Pro) variant causes a missense change. The variant allele was found at a frequency of 0.0000131 in 152,212 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. L111L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 33)

Consequence

HBB
NM_000518.5 missense

Scores

11
5
2

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:7O:1

Conservation

PhyloP100: 6.62
Variant links:
Genes affected
HBB (HGNC:4827): (hemoglobin subunit beta) The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 14 ACMG points.

PM1
In a hotspot region, there are 7 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 4 benign, 15 uncertain in NM_000518.5
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.898
PP5
Variant 11-5225710-A-G is Pathogenic according to our data. Variant chr11-5225710-A-G is described in ClinVar as [Pathogenic]. Clinvar id is 15352.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-5225710-A-G is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
HBBNM_000518.5 linkuse as main transcriptc.332T>C p.Leu111Pro missense_variant 3/3 ENST00000335295.4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
HBBENST00000335295.4 linkuse as main transcriptc.332T>C p.Leu111Pro missense_variant 3/31 NM_000518.5 P1
HBBENST00000647020.1 linkuse as main transcriptc.332T>C p.Leu111Pro missense_variant 3/3 P1
HBBENST00000475226.1 linkuse as main transcriptn.264T>C non_coding_transcript_exon_variant 2/22
HBBENST00000633227.1 linkuse as main transcriptc.*148T>C 3_prime_UTR_variant, NMD_transcript_variant 3/33

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152212
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000398
AC:
1
AN:
251248
Hom.:
0
AF XY:
0.00000736
AC XY:
1
AN XY:
135792
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Cov.:
31
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152212
Hom.:
0
Cov.:
33
AF XY:
0.0000269
AC XY:
2
AN XY:
74366
show subpopulations
Gnomad4 AFR
AF:
0.0000482
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000472
Hom.:
0
Bravo
AF:
0.0000113
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:7Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

beta Thalassemia Pathogenic:2
Pathogenic, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2017- -
Pathogenic, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpAug 26, 2016Variant summary: The HBB c.332T>C (p.Leu111Pro) variant causes a missense change involving a conserved nucleotide with 4/4 in silico tools (SNPs&GO not captured due to low reliability index) predicting a "damaging" outcome. The variant of interest was observed in the large, broad control population, ExAC, with an allele frequency of 1/121382, which does not exceed the estimated maximal expected allele frequency for a pathogenic HBB variant of 1/89. The variant of interest has been reported in multiple affected individuals in both homozygous and compound heterozygous states. In addition, a reputable database cites the variant as "pathogenic." Therefore, the variant of interest has been classified as Pathogenic. -
not provided Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingQuest Diagnostics Nichols Institute San Juan CapistranoMay 22, 2023The HBB c.332T>C (p.Leu111Pro) pathogenic variant (also known as Hb Showa-Yakushiji) is reported in the published literature as a hyper unstable variant associated with beta thalassemia major and intermedia (PMIDs: 28670940 (2017), 27263053 (2016), 18495504 (2008), 15768552 (2005), 2634667 (1989), 2822177 (1987)). Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded predictions that this variant is damaging. Based on the available information, this variant is classified as pathogenic. -
Pathogenic, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesMar 03, 2023The Hb Showa-Yakushiji variant (HBB: c.332T>C; p.Leu111Pro, also known as Leu110Pro when numbered from the mature protein, rs35256489, HbVar ID: 485) is reported to be a hyperunstable hemoglobin associated with beta(+) thalassemia (Colah 2008, Edison 2005, Kobayashi 1987, HbVar link). This variant is reported as pathogenic in ClinVar (Variation ID: 15352). It is only observed in one allele in the Genome Aggregation Database, indicating it is not a common polymorphism. The leucine at codon 111 is highly conserved, and computational analyses predict that this variant is deleterious (REVEL: 0.871). Based on available information, this variant is considered to be pathogenic. References: Link to HbVar database: https://globin.bx.psu.edu/hbvar/menu.html Colah R et al. Hb Showa Yakushiji (beta 110 (G12) Leu-->Pro) in 3 families from Western India: first report on homozygous Hb Showa Yakushiji. Blood Cells Mol Dis. 2008 Sep-Oct;41(2):166-8. PMID: 18495504. Edison ES et al. Hb Showa-Yakushiji (beta110(G12)Leu-->Pro) in four unrelated patients from west Bengal. Hemoglobin. 2005;29(1):19-25. PMID: 15768552. Kobayashi Y et al. A novel globin structural mutant, Showa-Yakushiji (beta 110 Leu-Pro) causing a beta-thalassemia phenotype. Blood. 1987 Nov;70(5):1688-91. PMID: 2822177. -
Beta-Showa-Yakushiji thalassemia Pathogenic:1
Pathogenic, no assertion criteria providedliterature onlyOMIMJan 01, 2005- -
Hb SS disease Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingBaylor Genetics-- -
Beta-plus-thalassemia Pathogenic:1
Pathogenic, no assertion criteria providedliterature onlyOMIMJan 01, 2005- -
HEMOGLOBIN SHOWA-YAKUSHIJI Other:1
other, no assertion criteria providedliterature onlyOMIMDec 12, 2017- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.98
BayesDel_addAF
Pathogenic
0.51
D
BayesDel_noAF
Pathogenic
0.50
Cadd
Uncertain
24
Dann
Uncertain
1.0
DEOGEN2
Benign
0.19
T;T
Eigen
Uncertain
0.66
Eigen_PC
Uncertain
0.54
FATHMM_MKL
Uncertain
0.92
D
M_CAP
Pathogenic
0.54
D
MetaRNN
Pathogenic
0.90
D;D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
4.1
H;H
MutationTaster
Benign
1.0
A
PrimateAI
Uncertain
0.55
T
PROVEAN
Pathogenic
-5.3
D;.
REVEL
Pathogenic
0.87
Sift
Pathogenic
0.0
D;.
Sift4G
Pathogenic
0.0010
D;.
Polyphen
1.0
D;D
Vest4
0.92
MutPred
0.67
Loss of stability (P = 0.0971);Loss of stability (P = 0.0971);
MVP
0.90
MPC
0.30
ClinPred
1.0
D
GERP RS
4.7
Varity_R
0.98
gMVP
0.97

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs35256489; hg19: chr11-5246940; API